New positron emission tomography (PET) radioligand for imaging σ-1 receptors in living subjects

Journal of Medicinal Chemistry

Volumn 55, Issue 19, 2012, Pages 8272-8282

  James, Michelle L ^a   Shen, Bin ^a   Zavaleta, Cristina L ^a   Nielsen, Carsten H ^a,b   Mesangeau, Christophe ^c   Vuppala, Pradeep K ^c   Chan, Carmel ^a   Avery, Bonnie A ^c   Fishback, James A ^d   Matsumoto, Rae R ^d   Gambhir, Sanjiv S ^a   McCurdy, Christopher R ^c   Chin, Frederick T ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 (3 FLUOROPROPYL) 3 (2 (AZEPAN 1 YL)ETHYL)BENZO[D]THIAZOL 2(3H) ONE F18; DELTA 1 RECEPTOR; HALOPERIDOL; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; DRUG SCREENING; DRUG SYNTHESIS; FLUORINATION; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY; RADIOFLUORINATION; RAT; WESTERN BLOTTING;

ANIMALS; AZEPINES; BENZOTHIAZOLES; BONE AND BONES; BRAIN; CHO CELLS; CRICETINAE; CRICETULUS; FLUORINE RADIOISOTOPES; LIVER; MICE; MICE, INBRED BALB C; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RECEPTORS, SIGMA; TISSUE DISTRIBUTION;

EID: 84867338447     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm300371c     Document Type: Article

References (58)

1. Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog J. Pharmacol. Exp. Ther. 1976, 197, 517-532
2. Martin, W. R. A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists NIDA Res. Monogr. 1984, 49, 16-23
3. Hellewell, S. B.; Bruce, A.; Feinstein, G.; Orringer, J.; Williams, W.; Bowen, W. D. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling Eur. J. Pharmacol. 1994, 268, 9-18
4. Maurice, T.; Su, T. P. The pharmacology of sigma-1 receptors Pharmacol. Ther. 2009, 124, 195-206
5. Guitart, X.; Codony, X.; Monroy, X. Sigma receptors: biology and therapeutic potential Psychopharmacology 2004, 174, 301-319
6. Walker, J. M.; Bowen, W. D.; Walker, F. O.; Matsumoto, R. R.; De Costa, B.; Rice, K. C. Sigma receptors: biology and function Pharmacol. Rev. 1990, 42, 355-402
7. Hayashi, T.; Su, T. P. Cholesterol at the endoplasmic reticulum: roles of the sigma-1 receptor chaperone and implications thereof in human diseases Subcell. Biochem. 2010, 51, 381-398
8. Su, T. P. Delineating biochemical and functional properties of sigma receptors: emerging concepts Crit. Rev. Neurobiol. 1993, 7, 187-203
9. Vilner, B. J.; John, C. S.; Bowen, W. D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines Cancer Res. 1995, 55, 408-413
10. Diaz, J. L.; Zamanillo, D.; Corbera, J.; Baeyens, J. M.; Maldonado, R.; Pericas, M. A.; Vela, J. M.; Torrens, A. Selective sigma-1 receptor antagonists: emerging target for the treatment of neuropathic pain Cent. Nerv. Syst. Agents Med. Chem. 2009, 9, 172-183
11. 11C]SA4503 Cent Nerv Syst Agents Med Chem. 2009, 9, 190-196
12. Narayanan, S.; Mesangeau, C.; Poupaert, J. H.; McCurdy, C. R. Sigma receptors and cocaine abuse Curr. Top. Med. Chem. 2011, 11, 1128-1150
13. Ishikawa, M.; Hashimoto, K. The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases J. Recept., Ligand Channel Res. 2009, 2010, 25-36
14. Wang, B.; Rouzier, R.; Albarracin, C. T.; Sahin, A.; Wagner, P.; Yang, Y.; Smith, T. L.; Meric-Bernstam, F.; Marcelo Aldaz, C.; Hortobagyi, G. N.; Pusztai, L. Expression of sigma 1 receptor in human breast cancer Breast Cancer Res. Treat. 2004, 87, 205-214
15. 3H]dopamine from guinea pig striatal slices is modulated by sigma1 receptor agonists Naunyn Schmiedeberg's Arch. Pharmacol. 1997, 356, 455-461
16. Kobayashi, T.; Matsuno, K.; Nakata, K.; Mita, S. Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain J. Pharmacol. Exp. Ther. 1996, 279, 106-113
17. Collier, T. L.; Waterhouse, R. N.; Kassiou, M. Imaging sigma receptors: applications in drug development Curr. Pharm. Des. 2007, 13, 51-72
18. Maurice, T. Improving Alzheimer's disease-related cognitive deficits with sigma 1 receptor agonists Drug News Perspect. 2002, 15, 617-625
19. Senda, T.; Matsuno, K.; Kobayashi, T.; Nakazawa, M.; Nakata, K.; Mita, S. Ameliorative effect of SA4503, a novel cognitive enhancer, on the basal forebrain lesion-induced impairment of the spatial learning performance in rats Pharmacol., Biochem. Behav. 1998, 59, 129-134
20. Harukuni, I.; Bhardwaj, A.; Shaivitz, A. B.; DeVries, A. C.; London, E. D.; Hurn, P. D.; Traystman, R. J.; Kirsch, J. R.; Faraci, F. M. Sigma-1 receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion Stroke 2000, 31, 976-982
21. Volz, H. P.; Stoll, K. D. Clinical trials with sigma ligands Pharmacopsychiatry 2004, 37 (Suppl. 3) S214-S220
22. Xu, Y. T.; Kaushal, N.; Shaikh, J.; Wilson, L. L.; Mesangeau, C.; McCurdy, C. R.; Matsumoto, R. R. A novel substituted piperazine, CM156, attenuates the stimulant and toxic effects of cocaine in mice J. Pharmacol. Exp. Ther. 2010, 333, 491-500
23. Romero, L.; Zamanillo, D.; Nadal, X.; Sanchez-Arroyos, R.; Rivera-Arconada, I.; Dordal, A.; Montero, A.; Muro, A.; Bura, A.; Segales, C.; Laloya, M.; Hernandez, E.; Portillo-Salido, E.; Escriche, M.; Codony, X.; Encina, G.; Burgueno, J.; Merlos, M.; Baeyens, J.; Giraldo, J.; Lopez-Garcia, J.; Maldonado, R.; Plata-Salaman, C.; Vela, J. Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization Br. J. Pharmacol. 2012, 166, 2289-2306
24. Quirion, R.; Bowen, W. D.; Itzhak, Y.; Junien, J. L.; Musacchio, J. M.; Rothman, R. B.; Su, T. P.; Tam, S. W.; Taylor, D. P. A proposal for the classification of sigma binding sites Trends Pharmacol. Sci. 1992, 13, 85-86
25. Ucar, H.; Cacciaguerra, S.; Spampinato, S.; Van derpoorten, K.; Isa, M.; Kanyonyo, M.; Poupaert, J. H. 2(3 H)-Benzoxazolone and 2(3 H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands Eur. J. Pharmacol. 1997, 335, 267-273
26. Berardi, F.; Ferorelli, S.; Abate, C.; Pedone, M. P.; Colabufo, N. A.; Contino, M.; Perrone, R. Methyl substitution on the piperidine ring of N -[ω-(6-methoxynaphthalen-1-yl)alkyl] derivatives as a probe for selective binding and activity at the sigma-1 receptor J. Med. Chem. 2005, 48, 8237-8244
27. Hudkins, R. L.; Mailman, R. B.; DeHaven-Hudkins, D. L. RLH-033, a novel, potent and selective ligand for the sigma 1 recognition site Eur. J. Pharmacol. 1994, 271, 235-236
28. Maestrup, E. G.; Fischer, S.; Wiese, C.; Schepmann, D.; Hiller, A.; Deuther-Conrad, W.; Steinbach, J.; Wunsch, B.; Brust, P. Evaluation of spirocyclic 3-(3-fluoropropyl)-2-benzofurans as sigma 1 receptor ligands for neuroimaging with positron emission tomography J. Med. Chem. 2009, 52, 6062-6072
29. Matsuno, K.; Nakazawa, M.; Okamoto, K.; Kawashima, Y.; Mita, S. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist Eur. J. Pharmacol. 1996, 306, 271-279
30. Moussa, I. A.; Banister, S. D.; Beinat, C.; Giboureau, N.; Reynolds, A. J.; Kassiou, M. Design, synthesis, and structure-affinity relationships of regioisomeric N -benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands J. Med. Chem. 2010, 53, 6228-6239
31. Piergentili, A.; Amantini, C.; Del Bello, F.; Giannella, M.; Mattioli, L.; Palmery, M.; Perfumi, M.; Pigini, M.; Santoni, G.; Tucci, P.; Zotti, M.; Quaglia, W. Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane J. Med. Chem. 2010, 53, 1261-1269
32. Quaglia, W.; Giannella, M.; Piergentili, A.; Pigini, M.; Brasili, L.; Di Toro, R.; Rossetti, L.; Spampinato, S.; Melchiorre, C. 1′-Benzyl-3,4- dihydrospiro[2 H -1-benzothiopyran-2,4′-piperidine] (spipethiane), a potent and highly selective sigma 1 ligand J. Med. Chem. 1998, 41, 1557-1560
33. Yous, S.; Wallez, V.; Belloir, M.; Caignard, D. H.; McCurdy, C. R.; Poupaert, J. H. Novel 2(3 H)-benzothiazolones as highly potent and selective sigma-1 receptor ligands Med. Chem. Res. 2005, 14, 158-168
34. 11C]SA4503 as a PET ligand for mapping CNS sigma-1 receptors Nucl. Med. Biol. 2000, 27, 255-261
35. Kawamura, K.; Tsukada, H.; Shiba, K.; Tsuji, C.; Harada, N.; Kimura, Y.; Ishiwata, K. Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma 1 receptor ligand for positron emission tomography Nucl. Med. Biol. 2007, 34, 571-577
36. 18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a selective sigma-1 receptor radioligand for PET Nucl. Med. Biol. 1997, 24, 127-134
37. 18F]SFE Mol. Imaging Biol. 2006, 8, 284-291
38. 18F]1-(2-fluoroethyl)-4-[(4-cyanophenoxy) methyl]piperidine as a potential radiotracer for PET assessment of CNS sigma-1 receptors Nucl. Med. Biol. 2006, 33, 211-215
39. 18F]fluspidine Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 540-551
40. Berardi, F.; Ferorelli, S.; Colabufo, N. A.; Leopoldo, M.; Perrone, R.; Tortorella, V. A multireceptorial binding reinvestigation on an extended class of sigma ligands: N -[omega-(indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards sigma1 and EBP sites Bioorg. Med. Chem. 2001, 9, 1325-1335
41. Shiba, K.; Ogawa, K.; Ishiwata, K.; Yajima, K.; Mori, H. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor Bioorg. Med. Chem. 2006, 14, 2620-2626
42. 11C]SA4503 Biol. Psychiatry 2007, 62, 878-883
43. Mishina, M.; Ohyama, M.; Ishii, K.; Kitamura, S.; Kimura, Y.; Oda, K.; Kawamura, K.; Sasaki, T.; Kobayashi, S.; Katayama, Y.; Ishiwata, K. Low density of sigma 1 receptors in early Alzheimer's disease Ann. Nucl. Med. 2008, 22, 151-156
44. 3H]-SN56, a novel radioligand for the σ1 receptor Eur. J. Pharmacol. 2011, 653, 1-7
45. McCurdy, C. R.; Mesangeau, C.; Chin, F. T.; James, M. L.; Shen, B.; Gambhir, S. S. Highly selective sigma receptor radioligands. U.S. Patent Application no. 13/151,084, filed June 2, 2011.
46. Poole, S. K.; Patel, S.; Dehring, K.; Workman, H.; Poole, C. F. Determination of acid dissociation constants by capillary electrophoresis J. Chromatogr., A 2004, 1037, 445-454
47. Danielsson, L. G.; Zhang, Y. H. Methods for determining n -octanol-water partition constants TrAC, Trends Anal. Chem. 1996, 15, 188-196
48. Poupaert, J.; Gbaguidi, F. A.; Kapanda, C. N.; Aichaoui, H.; McCurdy, C. R. Is cocaine a social drug? Exploration of the stereo-structure of cocaine's pharmacophore Med. Chem. Res. 2012, 21, 1-6
49. McCann, D. J.; Weissman, A. D.; Su, T. P. Sigma-1 and sigma-2 sites in rat brain: comparison of regional, ontogenetic, and subcellular patterns Synapse 1994, 17, 182-189
50. Matsumoto, R. R.; Pouw, B. Correlation between neuroleptic binding to sigma-1 and sigma-2 receptors and acute dystonic reactions Eur. J. Pharmacol. 2000, 401, 155-160
51. Vilner, B. J.; Bowen, W. D. Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture Eur. J. Pharmacol. 1993, 244, 199-201
52. 18F]fluspidine Eur. J. Nucl. Med. Mol. Imaging 2010, 38, 540-551
53. Mavlyutov, T. A.; Epstein, M. L.; Andersen, K. A.; Ziskind-Conhaim, L.; Ruoho, A. E. The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study Neuroscience 2010, 167, 247-255
54. Matsumoto, R. R.; Shaikh, J.; Wilson, L. L.; Vedam, S.; Coop, A. Attenuation of methamphetamine-induced effects through the antagonism of sigma receptors: evidence from in vivo and in vitro studies Eur. Neuropsychopharmacol. 2008, 18, 871-881
55. Kaushal, N.; Robson, M. J.; Vinnakota, H.; Narayanan, S.; Avery, B. A.; McCurdy, C. R.; Matsumoto, R. R. Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[ d ]oxazol-2(3 H)-one (SN79), a cocaine antagonist, in rodents AAPS J. 2011, 13, 336-346
56. Xu, Y. T.; Kaushal, N.; Shaikh, J.; Wilson, L. L.; Mesangeau, C.; McCurdy, C. R.; Matsumoto, R. R. A novel substituted piperazine, CM156, attenuates the stimulant and toxic effects of cocaine in mice J. Pharmacol. Exp. Ther. 2010, 333, 491-500
57. Fishback, J. A. New Methodologies for in Vitro Analysis of Binding and Functional Activity of Sigma Receptor Ligands. Ph.D. Dissertation, West Virginia University, Morgantown, WV, 2011.
58. Loening, A. M.; Gambhir, S. S. AMIDE: a free software tool for multimodality medical image analysis Mol. Imaging 2003, 2, 131-137